vTv Therapeutics
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell VTVT and other ETFs, options, and stocks.About VTVT
vTv Therapeutics, Inc. is a clinical-stage biopharmaceutical company engaged in the discovery and development of orally administered small molecule drug candidates to fill significant unmet medical needs. Its products target the treatment of central nervous system disorders, diabetes and metabolic disorders, inflammation, and cancer.
CEOPaul Jai Sekhri
CEOPaul Jai Sekhri
Employees23
Employees23
HeadquartersHigh Point, North Carolina
HeadquartersHigh Point, North Carolina
Founded2015
Founded2015
Employees23
Employees23
VTVT Key Statistics
Market cap113.59M
Market cap113.59M
Price-Earnings ratio-8.24
Price-Earnings ratio-8.24
Dividend yield—
Dividend yield—
Average volume10.07K
Average volume10.07K
High today$27.68
High today$27.68
Low today$25.98
Low today$25.98
Open price$25.98
Open price$25.98
Volume8.38K
Volume8.38K
52 Week high$33.16
52 Week high$33.16
52 Week low$13.15
52 Week low$13.15
Stock Snapshot
As of today, vTv Therapeutics(VTVT) shares are valued at $27.37. The company's market cap stands at 113.59M, with a P/E ratio of -8.24.
As of 2025-12-04, vTv Therapeutics(VTVT) stock has fluctuated between $25.98 and $27.68. The current price stands at $27.37, placing the stock +5.4% above today's low and -1.1% off the high.
vTv Therapeutics(VTVT) shares are trading with a volume of 8.38K, against a daily average of 10.07K.
During the past year, vTv Therapeutics(VTVT) stock moved between $13.15 at its lowest and $33.16 at its peak.
During the past year, vTv Therapeutics(VTVT) stock moved between $13.15 at its lowest and $33.16 at its peak.
People also own
Based on the portfolios of people who own VTVT. This list is generated using Robinhood data, and it’s not a recommendation.